China Tower’s Stock Price Drops to 1.19 HKD, Experiencing a 0.83% Decline

China Tower (788)

1.19 HKD -0.01 (-0.83%) Volume: 444.82M

China Tower’s stock price stands at 1.19 HKD, experiencing a slight decrease by -0.83% this trading session, with a notable trading volume of 444.82M. Despite today’s dip, the stock showcases a positive year-to-date performance with a rise of +6.25%, indicating a steady growth in its market value.

Latest developments on China Tower

China Tower’s stock price experienced fluctuations today following the announcement of their partnership with Huawei to develop 5G network infrastructure. This news comes after reports of increased competition in the telecommunications industry, with China Tower facing pressure from rival companies. Investors are closely monitoring the company’s performance as they navigate these challenges and seek to capitalize on the opportunities presented by the growing demand for 5G technology. Analysts are optimistic about China Tower’s long-term prospects, but caution that the stock price may continue to be influenced by market trends in the short term.

China Tower on Smartkarma

Analyst coverage on China Tower on Smartkarma indicates potential changes in the FXI ETF. According to Brian Freitas, China Tower (788 HK) is set to replace China International Capital Corporation (3908 HK) in the iShares China Large-Cap (FXI) at the close on 20 September. Passives are expected to buy 2x ADV in China Tower, with more positioning and short interest seen in CICC. This shift could be influenced by the listing of Midea Group Co Ltd A (000333 CH) H-shares, potentially leading to further ETF changes before the scheduled rebalance in December.

In a preview of the FXI rebalance, Brian Freitas suggests that China Tower (788 HK) has a high probability of replacing CICC in the ETF. While shorts have been covering China Tower and increasing in CICC, the cumulative excess volume curve has recently flattened out. With the review cutoff completed, only one change is anticipated for the FXI ETF in September. Both stocks have seen an increase in cumulative excess volume in recent months, although the pace has slowed in the recent past, indicating a potential shift in investor sentiment towards China Tower over CICC.

A look at China Tower Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Tower Corporation Limited, a telecommunications company, seems to have a promising long-term outlook based on its Smartkarma Smart Scores. With a top score of 5 in both Value and Dividend, the company appears to be financially sound and committed to rewarding its investors. Although its Growth score is slightly lower at 3, indicating moderate growth potential, China Tower’s overall resilience and momentum scores suggest stability and steady progress in the market.

Operating throughout China, China Tower focuses on telecommunication tower construction, maintenance, and ancillary facilities management. Despite facing challenges in the industry, the company’s strong value and dividend scores reflect its solid foundation and commitment to providing essential services in the telecommunications sector. With a balanced combination of growth potential, resilience, and momentum, China Tower seems well-positioned for future success in the market.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma